Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.

Rava A, Di Trapano M, Tse C, Ji L, Bid HK, Trezza V

Open source

DOI
10.1016/j.neubiorev.2026.107005
Published
2026 Dec
Container
Neuroscience and biobehavioral reviews
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.neubiorev.2026.107005,
  title = {Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.},
  author = {Rava A and Di Trapano M and Tse C and Ji L and Bid HK and Trezza V},
  year = {2026},
  journal = {Neuroscience and biobehavioral reviews},
  doi = {10.1016/j.neubiorev.2026.107005},
  url = {https://doi.org/10.1016/j.neubiorev.2026.107005}
}

RIS

TY  - JOUR
TI  - Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.
AU  - Rava A
AU  - Di Trapano M
AU  - Tse C
AU  - Ji L
AU  - Bid HK
AU  - Trezza V
PY  - 2026
JO  - Neuroscience and biobehavioral reviews
DO  - 10.1016/j.neubiorev.2026.107005
UR  - https://doi.org/10.1016/j.neubiorev.2026.107005
ER  - 

APA

A, R., M, D. T., C, T., L, J., HK, B., & V, T. (2026). Acidic cannabinoids in brain disorders: Neurobiological mechanisms, preclinical evidence, and translational challenges.. Neuroscience and biobehavioral reviews. https://doi.org/10.1016/j.neubiorev.2026.107005

Source records